(Q28076502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

1 reference

14 September 2020

anticholesteremic agents

1 reference

Massimiliano Pio di Cagno

18 December 2020

neuroprotective agent

1 reference

26 January 2021

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

author name string

Massimiliano di Cagno

series ordinal

1

1 reference

language of work or name

1 reference

25 December 2016

4 references

14 September 2020

18 December 2020

26 January 2021

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

14 September 2020

18 December 2020

26 January 2021

22

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

Creative Commons Attribution

12 May 2020

copyright license

3 references

14 September 2020

18 December 2020

26 January 2021

0 references

Review: a history of cyclodextrins.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Facile synthesis of beta-cyclodextrin-dextran polymers by "click" chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Population characteristics of cyclodextrin complex stabilities in aqueous solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cyclodextrins as pharmaceutical solubilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Evaluation of cyclodextrin solubilization of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Self-association and cyclodextrin solubilization of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Origin of non-linearity in phase solubility: solubilisation by cyclodextrin beyond stoichiometric complexation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cyclodextrins in Food Technology and Human Nutrition: Benefits and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cyclodextrins and their pharmaceutical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Calorimetric measurement of phospholipid interaction with methyl-beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Interactions of Cholesterol with Cyclodextrins in Aqueous Solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Molecular mechanism of cyclodextrin mediated cholesterol extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Depletion with Cyclodextrin Reveals Two Populations of Cholesterol in Model Lipid Membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Effects of cyclodextrins on the structure of LDL and its susceptibility to copper-induced oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and (1)H NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Effects of hydroxylpropyl-β-cyclodextrin on in vitro insulin stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

The role of lipid rafts in cancer cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Why high cholesterol levels help hematological malignancies: role of nuclear lipid microdomains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Membrane rafts as a novel target in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

HP-β-cyclodextrin as an inhibitor of amyloid-β aggregation and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Effects of cyclodextrin in two patients with Niemann-Pick Type C disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann-Pick Type C disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Phase solubility studies and stability of cholesterol/β-cyclodextrin inclusion complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Crystalline Cyclodextrin Inclusion Compounds Formed with Aromatic Guests: Guest-Dependent Stoichiometries and Hydration-Sensitive Crystal Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Investigating the inclusion properties of aromatic amino acids complexing beta-cyclodextrins in model peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Synthesis and characterization of poly(ethylene glycol) based β-cyclodextrin polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010001

Partial purification and properties of cyclodextrin glycosiltransferase (CGTase) from alkalophilic Bacillus species

21 January 2018

1 reference

12 December 2020

β-CD-dextran polymer for efficient sequestration of cholesterol from phospholipid bilayers: Mechanistic and safe-toxicity investigations

1 reference

12 December 2020

Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studies

1 reference

12 December 2020

Effect of cyclodextrin on plasma lipids and cholesterol metabolism in the rat

1 reference

12 December 2020

The Stability of Cyclodextrin Complexes in Solution

1 reference

12 December 2020

Composition and functional properties of cholesterol reduced egg yolk

1 reference

12 December 2020

Studies on the Schardinger dextrins. XI. The isolation of new Schardinger dextrins

1 reference

12 December 2020

Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro

1 reference

12 December 2020

Rafting through traffic: Membrane domains in cellular logistics

1 reference

12 December 2020

Cyclodextrin Drug Carrier Systems

1 reference

12 December 2020

Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease

1 reference

12 December 2020

10.3390/MOLECULES22010001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6155938&resulttype=core&format=json

12 May 2020

PubMed publication ID

2 references